Özlem TÜRECİ became a hope for the world. We can call it cancer-free He has been researching cancer for more than 20 years. Developing SEREX technology for characterization of tumor antigens, Türeci won the German Hematology and Oncology Association Vincenz Czerny Award and the University Saarland's Calogero Pagliarello Research Award in 1997.
He is also the founder and chief physician of longing derivative ganymed pharmaceuticals, one of the world's leading cancer researchers.